Abstract

The first human clinical study for NMN has started in Japan.

Highlights

  • In the recently published review in npj Aging and Mechanisms of Disease, Imai and Guarente[1] have provided a stimulating review about the role of nicotinamide adenine dinucleotide (NAD) in aging

  • Dietary restriction and exercise appear to be the realistic interventions, but both requires modest lifestyle modification which may be difficult for some individuals to implement. mechanistic target of rapamycin (mTOR) inbibitors, as well as telomere modifiers, can be good practical targets, but they are still under investigation

  • Metformin and acarbose are considered to be possible anti-aging drugs which are ready for a clinical trial in the US.[4]

Read more

Summary

Introduction

In the recently published review in npj Aging and Mechanisms of Disease, Imai and Guarente[1] have provided a stimulating review about the role of nicotinamide adenine dinucleotide (NAD) in aging. Sir[2] family proteins, called sirtuins, and NAD have attracted researchers’ significant attention for the intervention to promote longevity. As in tango, both sirtuins and NAD are necessary for healthy aging and longevity.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call